NCT01702155View on ClinicalTrials.gov

Phase I/II Study of DFP-10917 in Patients With Acute Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

October 10, 2012

Primary Completion Date

January 18, 2017

Study Completion Date

October 11, 2017

Conditions
Acute Myeloid LeukemiaAcute Lymphocytic Leukemia
Interventions
DRUG

DFP-10917

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Delta-Fly Pharma, Inc.

INDUSTRY